{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:48:52Z","timestamp":1790196532509,"version":"4.1.0"},"reference-count":38,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21lm0203143"],"award-info":[{"award-number":["JP21lm0203143"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,3,29]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Neonatal hypoxic-ischaemic encephalopathy (HIE) is an important illness associated with death or cerebral palsy. This study aims to assess the safety and tolerability of the allogenic human multilineage-differentiating stress-enduring cell (Muse cell)-based product (CL2020) cells in newborns with HIE. This is the first clinical trial of CL2020 cells in neonates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a single-centre, open-label, dose-escalation study enrolling up to 12 patients. Neonates with HIE who receive a course of therapeutic hypothermia therapy, which cools to a body temperature of 33\u00b0C\u201334\u00b0C for 72 hours, will be included in this study. A single intravenous injection of CL2020 cells will be administered between 5 and 14 days of age. Subjects in the low-dose and high-dose cohorts will receive 1.5 and 15 million cells per dose, respectively. The primary outcome is the occurrence of any adverse events within 12 weeks after administration. The main secondary outcome is the Bayley Scales of Infant and Toddler Development Third Edition score and the developmental quotient per the Kyoto Scale of Psychological Development 2001 at 78 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study will be conducted in accordance with the Declaration of Helsinki and Good Clinical Practice. The Nagoya University Hospital Institutional Review Board (No. 312005) approved this study on 13 November 2019. The results of this study will be published in peer-reviewed journal and reported in international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04261335\">NCT04261335<\/jats:ext-link>\n                      , jRCT2043190112.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-057073","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T08:09:30Z","timestamp":1652774970000},"page":"e057073","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct04261335","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0096-0832","authenticated-orcid":false,"given":"Nao","family":"Matsuyama","sequence":"first","affiliation":[{"name":"Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9066-3489","authenticated-orcid":false,"given":"Shinobu","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Ueda","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8760-1404","authenticated-orcid":false,"given":"Toshihiko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan"},{"name":"Division of Neonatology, Tokyo Women's Medical University Medical Center East, Arakawa-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2114-9499","authenticated-orcid":false,"given":"Sakiko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Miura","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Biostatistics, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-9176","authenticated-orcid":false,"given":"Yoshiaki","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"2025120520444489000_12.4.e057073.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2010.05.010"},{"key":"2025120520444489000_12.4.e057073.2","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12233"},{"key":"2025120520444489000_12.4.e057073.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71048-5"},{"key":"2025120520444489000_12.4.e057073.4","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-012-0200-y"},{"key":"2025120520444489000_12.4.e057073.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.971127"},{"key":"2025120520444489000_12.4.e057073.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c363"},{"key":"2025120520444489000_12.4.e057073.7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000368396","article-title":"Administration of umbilical cord blood cells transiently decreased hypoxic-ischemic brain injury in neonatal rats","volume":"37","author":"Hattori","year":"2015","journal-title":"Dev Neurosci"},{"key":"2025120520444489000_12.4.e057073.8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2014.01.018","article-title":"Effects of intravenous administration of umbilical cord blood CD34(+) cells in a mouse model of neonatal stroke","volume":"263","author":"Tsuji","year":"2014","journal-title":"Neuroscience"},{"key":"2025120520444489000_12.4.e057073.9","doi-asserted-by":"crossref","DOI":"10.1038\/srep44111","article-title":"Rat umbilical cord blood cells attenuate hypoxic-ischemic brain injury in neonatal rats","volume":"7","author":"Nakanishi","year":"2017","journal-title":"Sci Rep"},{"key":"2025120520444489000_12.4.e057073.10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","article-title":"Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy","volume":"164","author":"Cotten","year":"2014","journal-title":"J Pediatr"},{"key":"2025120520444489000_12.4.e057073.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-61311-9","article-title":"Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety","volume":"10","author":"Tsuji","year":"2020","journal-title":"Sci Rep"},{"key":"2025120520444489000_12.4.e057073.12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000455836","article-title":"Dedifferentiated fat cells as a novel source for cell therapy to target neonatal hypoxic-ischemic encephalopathy","volume":"39","author":"Mikrogeorgiou","year":"2017","journal-title":"Dev Neurosci"},{"key":"2025120520444489000_12.4.e057073.13","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00987","article-title":"Administration of bone marrow-derived mononuclear cells contributed to the reduction of hypoxic-ischemic brain injury in neonatal rats","volume":"9","author":"Sato","year":"2018","journal-title":"Front Neurol"},{"key":"2025120520444489000_12.4.e057073.14","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00757","article-title":"Intravenous administration of bone marrow-derived mesenchymal stem cell, but not adipose tissue-derived stem cell, ameliorated the neonatal hypoxic-ischemic brain injury by changing cerebral inflammatory state in rat","volume":"9","author":"Sugiyama","year":"2018","journal-title":"Front Neurol"},{"key":"2025120520444489000_12.4.e057073.15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/scd.2019.0221","article-title":"A novel treatment with stem cells from human exfoliated deciduous teeth for hypoxic-ischemic encephalopathy in neonatal rats","volume":"29","author":"Kitase","year":"2020","journal-title":"Stem Cells Dev"},{"key":"2025120520444489000_12.4.e057073.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911647107"},{"key":"2025120520444489000_12.4.e057073.17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3727\/096368916X690881","article-title":"Muse cells provide the pluripotency of mesenchymal stem cells: direct contribution of Muse cells to tissue regeneration","volume":"25","author":"Dezawa","year":"2016","journal-title":"Cell Transplant"},{"key":"2025120520444489000_12.4.e057073.18","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12129"},{"key":"2025120520444489000_12.4.e057073.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311648"},{"key":"2025120520444489000_12.4.e057073.20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/cells1041045","article-title":"Regenerative effects of mesenchymal stem cells: contribution of Muse cells, a novel pluripotent stem cell type that resides in mesenchymal cells","volume":"1","author":"Wakao","year":"2012","journal-title":"Cells"},{"key":"2025120520444489000_12.4.e057073.21","first-page":"305","volume-title":"Muse cells. advances in experimental medicine and biology","volume":"vol. 1103","author":"Dezawa","year":"2018"},{"key":"2025120520444489000_12.4.e057073.22","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1177\/0271678X20972656","article-title":"Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy","volume":"41","author":"Suzuki","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"2025120520444489000_12.4.e057073.23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1253\/circj.CJ-20-0307","article-title":"Safety and efficacy of human Muse cell-based product for acute myocardial infarction in a first-in-human trial","volume":"84","author":"Noda","year":"2020","journal-title":"Circ J"},{"key":"2025120520444489000_12.4.e057073.24","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1111\/jdv.17201","article-title":"Intravenous allogeneic multilineage-differentiating stress-enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1\/2 open-label study","volume":"35","author":"Fujita","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025120520444489000_12.4.e057073.25","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1976.00500100030012"},{"key":"2025120520444489000_12.4.e057073.26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/STROKEAHA.119.026589","article-title":"Intravenously transplanted human multilineage-differentiating stress-enduring cells afford brain repair in a mouse lacunar stroke model","volume":"51","author":"Abe","year":"2020","journal-title":"Stroke"},{"key":"2025120520444489000_12.4.e057073.27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0738-081X(89)90010-2","article-title":"Corticosteroids","volume":"7","author":"Lester","year":"1989","journal-title":"Clin Dermatol"},{"key":"2025120520444489000_12.4.e057073.28","doi-asserted-by":"crossref","unstructured":"Bayley N . Bayley scales of infant and toddler development. 3rd ed. San Antonio, TX: Psychological Corp, 2006.","DOI":"10.1037\/t14978-000"},{"key":"2025120520444489000_12.4.e057073.29","unstructured":"Society for the Kyoto Scale of Psychological Development . The Kyoto scale of psychological development 2001: information for standardization and administration. Kyoto, Japan: Kyoto Kokusai Shakai Fukushi Center, 2002."},{"key":"2025120520444489000_12.4.e057073.30","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12550"},{"key":"2025120520444489000_12.4.e057073.31","first-page":"143","article-title":"Prediction of neuromotor outcome in perinatal asphyxia: evaluation of Mr scoring systems","volume":"19","author":"Barkovich","year":"1998","journal-title":"AJNR Am J Neuroradiol"},{"key":"2025120520444489000_12.4.e057073.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2008.03089.x"},{"key":"2025120520444489000_12.4.e057073.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900854"},{"key":"2025120520444489000_12.4.e057073.34","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2011.43"},{"key":"2025120520444489000_12.4.e057073.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17946-X"},{"key":"2025120520444489000_12.4.e057073.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcps050929"},{"key":"2025120520444489000_12.4.e057073.37","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2441"},{"key":"2025120520444489000_12.4.e057073.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.03.030"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-057073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:44:58Z","timestamp":1764996298000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-057073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,26]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1136\/bmjopen-2021-057073"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-057073","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}